Showing 1 - 10 of 25
Persistent link: https://www.econbiz.de/10010723913
Persistent link: https://www.econbiz.de/10007373584
Persistent link: https://www.econbiz.de/10004757688
This paper critically evaluates the recent shift away from a “thin” reading of monetary exchange, which views money transactions as universally market-like and profit-motivated, towards “thicker” readings of exchange, which identify the permeation of wider economic relations and...
Persistent link: https://www.econbiz.de/10008674644
Age-related macular degeneration (AMD) is a leading cause of blindness in people aged ≥50 years. Wet AMD in particular has a major impact on patient quality of life and imposes substantial burdens on healthcare systems. This systematic review examined the cost-effectiveness data for current...
Persistent link: https://www.econbiz.de/10011001443
Age-related macular degeneration (AMD) is a leading cause of blindness in people aged ≥50 years. Wet AMD in particular has a major impact on patient quality of life and imposes substantial burdens on healthcare systems. This systematic review examined the cost-effectiveness data for current...
Persistent link: https://www.econbiz.de/10010614298
In economic evaluation, mathematical models have a central role as a way of integrating all the relevant information about a disease and health interventions, in order to estimate costs and consequences over an extended time horizon. Models are based on scientific knowledge of disease (which is...
Persistent link: https://www.econbiz.de/10010680797
Pharmacoeconomic studies using claims data are frequently employed to compare the healthcare costs associated with competing drugs. Different methodological approaches with varying limitations for evaluating claims data are reviewed within the context of psychosis. Intent-to-treat paradigms and...
Persistent link: https://www.econbiz.de/10005404897
Persistent link: https://www.econbiz.de/10005376478
A number of UK industries are heavily dependent on the government as a major purchaser. The Ministry of Defence and the National Health Service are essentially monopsonists for the industries supplying them. As a monopsonist, government can influence the size, structure, conduct and performance...
Persistent link: https://www.econbiz.de/10005643763